News


Calyxt Announces Stockholder Approval of Merger With Cibus

Calyxt Announces Stockholder Approval of Merger With Cibus

—Calyxt Announces 1-for-5 Reverse Stock Split of Common Stock— ROSEVILLE, MN, May 19, 2023 (PR NEWSWIRE) – Calyxt, Inc. (Nasdaq:...
Read More
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update

Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update

—Proposed merger with Cibus Global Expected to Close in Q2 2023— —1-for-10 reverse stock split executed— —Current customer projects under...
Read More
Calyxt Completes One-for-Ten Reverse Stock Split

Calyxt Completes One-for-Ten Reverse Stock Split

ROSEVILLE, MN, April 24, 2023 (PR NEWSWIRE) – Calyxt, Inc. (Nasdaq: CLXT) (“Calyxt” or the “Company”) today announced that it...
Read More
Calyxt, Inc. Announces Effectiveness of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC

Calyxt, Inc. Announces Effectiveness of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC

ROSEVILLE, Minn. and SAN DIEGO– April 18, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, and...
Read More
Calyxt Announces Effective Date of Reverse Stock Split

Calyxt Announces Effective Date of Reverse Stock Split

ROSEVILLE, MN, April 7, 2023 (PR NEWSWIRE) – Calyxt, Inc. (Nasdaq: CLXT) (“Calyxt” or the “Company”) today announced that it...
Read More
Next »